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polytetrafluoroethylene carotid patches provide early
and late results that are equivalent to those for vein
patching,5,6 but our past experience could suggest
otherwise. In our entire series of 1924 isolated
CEAs from 1989 through 1995, the overall in-
hospital stroke risk associated with synthetic patches
(3.3%) was higher than that (1.3%) for vein patching
on multivariable analysis (odds ratio, 2.6; 95% CI,
1.2-5.3).7 Furthermore, in a subset of 314 patients
from this series for whom nonelective CEAs had
been performed, the Kaplan-Meier 5-year ipsilateral
stroke rate for vein patching (7.6%) was lower than
that (24%) for synthetic patches (P <.001).8
However, these findings must be interpreted cau-
tiously because we have traditionally used synthetic
patches only in patients whose greater saphenous
veins (GSVs) already had been harvested for coro-
nary bypass surgery or for infrainguinal revascular-
ization. Therefore, strokes could conceivably be
more prevalent in this population merely because of
widespread atherosclerosis.
Provided its neurologic results are eventually
shown conclusively to be comparable to those for
vein patch angioplasty, synthetic patching has the
obvious advantages of reducing operative time dur-
ing CEA, avoiding the occasional wound complica-
tions of a groin incision, and conserving an intact
saphenous system for other arterial reconstructions
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More than 10 years ago, we first discovered that,
at least in our hands, vein patch angioplasty
appeared to be superior to primary arteriotomy clo-
sure with respect to the risks for perioperative stroke,
internal carotid thrombosis, or recurrent stenosis in
conjunction with carotid endarterectomy (CEA).1
Several subsequent investigations have also conclud-
ed that patching significantly enhances the safety and
durability of CEA, including an early randomized
trial conducted by Eikelboom et al,2 the meta-
analysis of ipsilateral stroke rates in this trial and in
five similar trials by Counsell et al,3 and a recent
report of recurrence rates for the Asymptomatic
Carotid Atherosclerosis Study by Moore et al.4 In
comparison, relatively little information is available
regarding whether the type of patch material that is
used might also influence CEA outcomes.
Some case series indicate that either Dacron or
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From 1995 through 1998, we encountered eight patients with infected Dacron patches
after previous carotid endarterectomy. Two of the original operations had been done
elsewhere, but the six patients who were collected from our own series represented 0.5%
of the 1258 carotid endarterectomies we performed and 1.8% of the 340 synthetic
carotid patches we applied without any comparable infections among another 918
patients who received either vein patch angioplasty (n = 843) or primary arteriotomy
closure (n = 74) during the same 4-year study period. With a single exception (“no
growth”), bacterial cultures that were obtained at the time of the eight reoperations
revealed Staphylococcus (n = 4) or Streptococcus (n = 3) species. All of the infected Dacron
patches were removed and were replaced with saphenous vein patches (n = 5) or inter-
position grafts (n = 3), after which appropriate oral (n = 2) or intravenous (n = 6) antibi-
otics were administered for 2 to 6 weeks. No postoperative deaths occurred, but there
were 2 temporary cranial nerve injuries, 1 myocardial infarction, and 1 stroke that was
related to preoperative angiography. A recurrent carotid infection has not developed in
any of the eight patients during a mean follow-up interval of 16 months (range, 3-36
months). (J Vasc Surg 2000;32:602-6.)
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in the future. Nevertheless, the possibility of infec-
tion is a potential liability of synthetic patch materi-
als that has attracted scant attention in the literature
but constitutes the basis for this report.
CASE REPORTS
Patient information. On the basis of our computer
data registry, the members of our department performed
1258 CEAs from 1995 through 1998 (Table I). Most of
these patients (n = 1183, 94%) received patch angioplasty;
the GSV harvested from the groin was used in 843 patients
(67%). If the GSVs were no longer available because of pre-
vious coronary bypass surgery or infrainguinal revascular-
ization, either Dacron (n = 322, 26%) or polytetrafluo-
roethylene (n = 18, 1.4%) patches were constructed instead
in 340 patients (27%). Only 75 arteriotomies (6%) were
repaired primarily. According to a relatively standardized
protocol, other routine measures included intraoperative
carotid shunting, partial reversal of heparin with protamine
sulfate at the conclusion of the procedure, and the admin-
Preoperative angiograms for the two patients who had carotid pseudoaneurysms. A, Patient 5; B,
patient 7.
A B
Table I. Method of arteriotomy closure
Vein patch Synthetic patch No patch
Year Total CEAs No. % No. % No. %
1995 361 280 78 66 18 15 4
1996 335 220 66 99 30 16 5
1997 305 185 61 94 31 26 9
1998 257 158 61 81 32 18 7
Total 1258 843 67 340 27 75 6
CEAs, Carotid endarterectomies.
Table II. Infected arteriotomy closures
Infections Vein patch Synthetic patch No patch
Year No. % No. % No. % No. %
1995 1 0.3 0 — 1 1.5 0 —
1996 1 0.3 0 — 1 1 0 —
1997 2 0.7 0 — 2 2.1 0 —
1998 2 0.8 0 — 2 2.5 0 —
Total 6 0.5 0 — 6 1.8 0 —
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istration of perioperative intravenous antibiotics beginning
before the skin incision. Silastic vacuum drains that were
removed on the following morning were used during most
autogenous procedures. Drains were not used often in con-
junction with synthetic patching, but this decision was a
matter of surgeon preference.
During the 4 years comprising our study period, we
encountered eight patients for whom carotid reoperations
later became necessary because of infected synthetic patch-
es (all Dacron) after CEA. Two of the original operations
had been done elsewhere. However, the remaining six
patients were collected from our own series and represent-
ed 0.5% of the 1258 CEAs we performed and 1.8% of the
340 synthetic patches we applied from 1995 through 1998
(Table II). In comparison, there have been no autogenous
carotid infections after another 918 procedures in which
vein patches or primary arteriotomy closure was used.
Patch infections occurred in six men and in two women,
ranging from 48 to 85 years of age (mean age, 68 years).
Although their incidence of hypertension and/or coronary
artery disease (n = 6, 75%) was not unusual for patients
undergoing CEA, it may be notable that five (62%) of these
eight patients had diabetes. Infected patches were discovered
from 13 to 1060 days (mean, 274 days or approximately 9
months) after CEA, the diagnosis usually being suspected
because of one or more typical clinical features, such as a
draining cutaneous sinus, local tenderness or a cervical mass,
wound erythema, and fever. One patient was found to have
a patch pseudoaneurysm with duplex ultrasound scanning.
Preoperative duplex scans also were obtained in four addi-
tional patients, revealing fluid collections or stable
hematomas each in two patients. Carotid angiograms were
performed before three reoperations, providing some useful
information regarding the cephalad extent of the infected
patches, but failing to identify pseudoaneurysms in the two
patients who had them (Figure). 
Surgical management. The principles of reoperative
surgical treatment included complete excision of the infect-
ed patch, its replacement with either a saphenous vein patch
or a venous interposition graft to the internal carotid artery
(ICA), extensive debridement of all inflammatory tissue,
and the submission of intraoperative cultures to guide post-
operative antibiotic therapy. Adequate exposure was neces-
sary to protect the vagus and hypoglossal nerves as well as
the ICA in a difficult surgical field, and this often required
nasotracheal intubation, transection of the omohyoid and
posterior digastric muscles for proximal and distal arterial
control, and division of the occipital artery and the descend-
ing branch of the hypoglossal nerve to gain access to the
ICA above the infected patch. Carotid shunting was used
during seven of the eight reoperations, the only exception
being one case (patient 3) in which distal vascular exposure
was especially treacherous and vigorous ICA backbleeding
indicated the presence of adequate collateral circulation. 
RESULTS
Table III contains a summary of information for
each of the eight patients described in this report.
Perioperative antibiotics had been administered at
the time of the original CEAs that were performed
at our own center (patients 1-6), ranging from a sin-
gle preoperative dose in one patient, to a course of
10 days in another patient who had a postoperative
cervical hematoma. A cephalosporin derivative
(cefuroxime) was used routinely, but patients who
were allergic to penicillin instead received van-
comycin. Although no information was available
regarding the two CEAs that originally had been
performed elsewhere, incisional vacuum drains had
been placed in two of our six patients at the time of
their primary procedures. Reoperative bacterial cul-
tures were sterile in one patient, but revealed
Table III. Specific patient information
Original patch Perioperative Delay to
Age (y)/sex material antibiotics Diabetes diagnosis (d) Presenting symptoms
1. 65/m Dacron Cefuroxime No 236 Draining sinus
(48 h)
2. 63/m Dacron Cefuroxime Yes 43 Local  abscess
(single dose)
3. 78/m Dacron Cefuroxime Yes 13 Fever, pain, sinus 
(16 h)
4. 74/m Dacron Cefuroxime No 26 Draining sinus
(10 d)
5. 82/m Dacron Vancomycin No 1060 Expanding pseudoaneurysm
(24 h)
6. 49/f Dacron Vancomycin (12 h) Yes 32 Local abscess
7. 85/m* Dacron Unknown Yes 750 Patch disruption, hemorrhage
8. 48/f* Dacron Unknown Yes 29 Pain, mass, sinus
*Original operation elsewhere.
IV, Intravenous; f, female; LOS, hospital length of stay; m, male.
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Staphylococcus or Streptococcus species in all others.
After excision of the infected patches and debride-
ment of surrounding inflammatory tissue, the integri-
ty of the carotid bifurcation was sufficiently preserved
to permit arterial repair with a saphenous vein patch
in five patients. Reversed saphenous vein grafts were
constructed from the common carotid artery to the
ICA in three others, including one (patient 7) who
had presented urgently with disruption of his infected
patch and hemorrhage from a cutaneous sinus tract
after simple surgical drainage of a chronic cervical
abscess at another hospital (Figure, B).
There were no postoperative deaths, and the only
stroke that occurred (patient 5) was causally related
to the angiogram that was performed before the
reoperation for an infected patch pseudoaneurysm.
One patient had a perioperative myocardial infarc-
tion, and two others sustained temporary cranial
nerve dysfunction that eventually resolved sponta-
neously. The mean length of stay in the hospital was
7 days, but according to the results of their intraop-
erative bacterial cultures, all eight patients received
appropriate oral (n = 2) or home intravenous antibi-
otics (n = 6) for 2 to 6 weeks postoperatively. To
some extent the choice and duration of long-term
antibiotics may have reflected the individual prefer-
ences of medical consultants, but such factors as the
severity of the preoperative illness, the virulence of
cultured organisms, and the postoperative clinical
course also entered into consideration (Table III). 
Seven patients remain alive during follow-up
intervals ranging from 3 to 36 months (mean, 17
months). The remaining patient required lumbar
laminectomy for treatment of an unrelated epidural
abscess caused by a different organism (Pseudomonas
aeruginosa), regained his usual state of health, but
subsequently died as the result of an automobile
crash 6 months after his carotid reoperation. No late
strokes have occurred, and four of the seven surviv-
ing patients have been documented by duplex scan-
ning or angiography to have patent arterial recon-
stuctions (three vein patches, one interposition
graft). A recurrent carotid infection has not devel-
oped in any of the eight patients.
DISCUSSION
Local sepsis is an exceedingly unusual complica-
tion of CEA, and the previous literature contains
only scattered reports of carotid infections after pri-
mary arteriotomy repair or vein patch angioplasty.9-12
These infections, which usually have been caused by
gram-positive bacteria, almost by definition were
found to have infiltrated the arterial wall simply
because they had occurred after autogenous closures
in the first place. Therefore, excision of the carotid
bifurcation and the construction of a venous interpo-
sition graft to the ICA have generally been recom-
mended in the past, because the risk for stroke has
predictably been much lower with vein grafts than
with carotid ligation. Our current experience sug-
gests, however, that a synthetic patch infection may
be confined to the patch itself and can often be man-
aged safely by replacing the infected patch with a new
saphenous vein patch harvested from the groin. 
The incidence of synthetic patch infection during
our study period was 1.8%, a figure that can be com-
pared with some justification to the risk for aseptic
central vein patch rupture, which is the most cata-
strophic complication related to autogenous carotid
patching. Vein patch rupture may be even a less com-
Infecting Reoperation Antibiotics after 
organism performed LOS (d) reoperation Complications Follow-up
Staphylococcus Vein graft 6 Erythromycin Vocal cord Normal (2 y)
epidermidis (18 d, oral) paralysis
Staphylococcus Vein patch 12 Oxacillin Epidural Accidental death 
aureus (28 d, IV) abscess (6 mo)
Streptococcus Vein patch 13 Vancomycin, ciprofloxacin Myocardial Normal (1 y) 
milleri (42 d, IV) infarction
No growth Vein patch 7 Vancomycin (7 d, IV), None Normal (3 y)
cephalexin (14 d, oral)
S epidermidis Vein graft 4 Clindamycin (15 d, IV) Stroke, hypoglossal Minimal deficit (4 mo)
nerve injury
S milleri Vein patch 6 Vancomycin (28 d, IV) None Normal (2 y)
S aureus Vein graft 3 Vancomycin (15 d, IV) None Normal (3 mo)
Streptococcus mitis Vein patch 4 Cefazolin (21 d, IV) None Normal (16 mo)
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mon event than synthetic patch infection, occurring
in only 5 (0.1%) of 2888 CEAs at the Mayo Clinic,13
in 7 (0.4%) of 1691 CEAs at our center,14 and in 13
(0.7%) of 1760 CEAs collected from members of the
Western Vascular Society.15 Eighteen (72%) of these
25 ruptures were in women, and nearly all (24 of 25)
involved ankle veins. Archie16, 17 eventually conclud-
ed on the basis of extensive laboratory and clinical
studies that small vein diameter (< 3.5 mm)
supercedes the variables of sex and harvest site as the
principal factor contributing to patch rupture, but
because the diameter of the GSV is universally larger
in the upper thigh than in the lower leg, this obser-
vation implies that the GSV probably should be
obtained exclusively from the groin for carotid patch
angioplasty. Despite the fact that patch rupture virtu-
ally never occurs using this approach,14,18 Yamamoto
et al13 have adopted routine synthetic patching in
preference to vein patching because of the conve-
nience and the perceived safety of modern collagen-
impregnated Dacron patch materials.
Although we still believe that vein patch angioplas-
ty has an established role in CEA, we do not intend to
condemn synthetic, specifically Dacron, patches mere-
ly because of our current experience with a few patch
infections. Synthetic patches have relatively low com-
plication rates by any standard, and they appear to pro-
vide significant protection from recurrent stenosis in
comparison with primary arteriotomy closure.4 Patch
infection may be a random, unavoidable event; like
vein patch rupture, however, there could also be
underlying etiologic mechanisms that are not yet fully
appreciated. For example, five of our eight patients
had diabetes, and cervical drains had been used during
the original CEAs in at least two of them, both of
these features representing risk factors for wound
infection in previous anecdotal cases or retrospective
series.19, 20 A longer course of postoperative antibiotics
might be appropriate after synthetic carotid patching
in patients with diabetes, or perhaps in the presence of
other findings that were not documented in our chart
review, such as prominent cervical lymph nodes, poor
dental hygiene, or recent upper respiratory tract infec-
tions. None of these considerations can be substantiat-
ed, however, until much more information about
infected synthetic patches is reported.
Frances Federico assisted with the preparation of the
manuscript, and Becky Roberts maintains our department
database.
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